Website stats and analysis

What We DoGalectin's lead drug, belapectin (GR‑MD‑), is a carbohydrate-based drug that inhibits the galectin‑ protein, involved in many inflammatory, fibrotic, and malignant diseases. Learn More

2.48 Rating by Usitestat

galectintherapeutics.com was registered 1 decade 4 years ago. It has a alexa rank of #2,075,178 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, galectintherapeutics.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 422
Daily Pageviews: 844

Estimated Valuation

Income Per Day: $ 3.00
Estimated Worth: $ 720.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 2,075,178
PageSpeed Score: 89 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

66.96.161.165

Hosted Country:

United States US

Location Latitude:

42.5085

Location Longitude:

-71.2011

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For galectintherapeutics.com

Galectin Therapeutics Inc SEC Registration - SEC Report

- https://sec.report/CIK/0001133416

Galectin Therapeutics Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page ...


Galectin Therapeutics Company Profile: Stock Performance ...

- https://pitchbook.com/profiles/company/41495-14

Information on stock, financials, earnings, subsidiaries, investors, and executives for Galectin Therapeutics. Use the PitchBook Platform to explore the full profile.


Galectin Therapeutics - Overview, News & Competitors | ZoomInfo.com

- https://www.zoominfo.com/c/galectin-therapeutics-inc/348547947

View Galectin Therapeutics (www.galectintherapeutics.com) location in Georgia, United States , revenue, industry and description. Find related and similar ...


GALT.DF - Galectin Therapeutics Inc Profile | Reuters

- https://www.reuters.com/companies/GALT.DF

About Galectin Therapeutics Inc ... Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create ...


Galectins and Disease Implications for Targeted ... - ACS Publications

- https://pubs.acs.org/doi/pdf/10.1021/bk-2012-1115.ch001

Galectin Therapeutics, Inc., 4960 Peachtree Industrial Blvd., Suite 240,. Norcross, Georgia 30071. *E-mail: [email protected] (A.A.K);.


Galectin Therapeutics Company Profile - Office Locations ... -...

- https://craft.co/galectin-therapeutics

Galectin Therapeutics has 7 employees at their 1 location. See insights on Galectin Therapeutics including office locations, competitors, revenue, financials,  ...


Galectin Therapeutics Inc (GALT) Quote - XNAS | Morningstar

- https://www.morningstar.com/stocks/xnas/galt/quote

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for  ...


Galectin Therapeutics Inc - Company Profile and News - Bloomberg ...

- https://www.bloomberg.com/profile/company/GALT:US

Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate ...


GALT - Galectin Therapeutics Inc | Profile | OTC Markets

- https://www.otcmarkets.com/stock/GALT/profile

Galectin Therapeutics leverages its extensive scientific knowledge of galectins to advance their discovery program including research and discovery of new ...


Galectin Therapeutics Inc. (Nasdaq: GALT) :: LD Micro

- https://www.ldmicro.com/profile/galt

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for  ...


Fighting NASH Cirrhosis and Cancer

- https://galectintherapeutics.com/

Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin's lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.


Galectin Therapeutics: The Galectin Signature - Signed, Sealed ...

- https://seekingalpha.com/article/4419534-galectin-therapeutics-galectin-signature-signed-sealed-and-about-to-be-delivered

Apr 16, 2021 ... Galectin Therapeutics (GALT) was founded years ago building on the research of professors from Harvard and Weizmann, and has undergone ...


Galectin Therapeutics | The Org

- https://theorg.com/org/galectin-therapeutics

Galectin Therapeutics Inc (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.


Galectin's Competitors, Revenue, Number of Employees, Funding ...

- https://www.owler.com/company/galectintherapeutics

Website: http://galectintherapeutics.com/ ... Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, repo... See more » .


288: The Big Year | Jack Callicutt, CFO, Galectin Therapeutics -...

- https://cfothoughtleader.com/cfopodcasts/288-big-year-jack-callicutt-cfo-galectin-therapeutics/

288: The Big Year | Jack Callicutt, CFO, Galectin Therapeutics. To span the realm of opportunities in biotech is to gaze down an infinite loop of possibilities with ...


GALT: Galectin Therapeutics Inc. - Summary | Jitta

- https://www.jitta.com/stock/nasdaq:galt

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other ...


Atlanta : Galectin Therapeutics Raises $44.5 Million in ... -...

- https://atlanta.citybizlist.com/article/551824/galectin-therapeutics-raises-445-million-in-rights-offering

May 28, 2019 ... NORCROSS, Ga., May 28, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics ...


Galectin Therapeutics Inc company profile - Futubull

- https://www.futunn.com/en/stock/GALT-US/company-profile

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other ...


Galectin Therapeutics And CTI Announce Positive New Psoriasis ...

- https://www.ctifacts.com/news-events/2016/november/galectin-therapeutics-and-cti-announce-positive-new-psoriasis-and-atopic-dermatitis-clinical-data

Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's ...


Galectin Therapeutics Stock Analysis | GALT Stock Rating - TipRanks

- https://www.tipranks.com/stocks/galt/stock-analysis

Galectin Therapeutics stock analysis based on the TipRanks smart score of 8 unique data sets and technical analysis. Find the latest GALT stock analysis.


Galectin Therapeutics Inc. Warrants (GALTW) Stock Message Board ...

- https://investorshub.advfn.com/Galectin-Therapeutics-Inc-Warrants-GALTW-27913/

Company Name: Galectin Therapeutics Inc. Warrants, Stock Symbol: GALTW, Industry: Biotechs, Total Posts: 16, Last Post: 8/15/2014 8:34:32 PM.


Jobs with Galectin Therapeutics - BioSpace

- https://www.biospace.com/employer/546397/galectin-therapeutics/

Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a ...

Page Resources Breakdown

Homepage Links Analysis

Fighting NASH Cirrhosis and Cancer
Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.

Website Inpage Analysis

H1 Headings: 1 H2 Headings: 6
H3 Headings: 5 H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 5
Google Adsense: Not Applicable Google Analytics: UA-23609777-1

Two Phrase Analysis

Words Occurrences Density Possible Spam
Learn More 10 2.198 % No
NASH cirrhosis 7 1.538 % No
Galectin Therapeutics 5 1.099 % No
the NAVIGATE 3 0.659 % No
We Do 3 0.659 % No
What We 3 0.659 % No
Email Alert 3 0.659 % No
Alert Subscription 3 0.659 % No
News Contact 2 0.44 % No
Publications News 2 0.44 % No
Contact Us 2 0.44 % No
hope to 2 0.44 % No
Resources Publications 2 0.44 % No
cirrhosis is 2 0.44 % No
steatohepatitis NASH 2 0.44 % No
About the 2 0.44 % No
Belapectin About 2 0.44 % No
About Belapectin 2 0.44 % No
More About 2 0.44 % No
About Galectin3 2 0.44 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
Learn More About Belapectin 2 0.44 % No
Subscription Learn More About 2 0.44 % No
Alert Subscription Learn More 2 0.44 % No
More About Belapectin About 2 0.44 % No
About Belapectin About Galectin3 2 0.44 % No
About Galectin3 About the 2 0.44 % No
Belapectin About Galectin3 About 2 0.44 % No
Email Alert Subscription Learn 2 0.44 % No
FAQs Email Alert Subscription 2 0.44 % No
Governance Financial Information Stock 2 0.44 % No
Corporate Governance Financial Information 2 0.44 % No
Financial Information Stock Information 2 0.44 % No
Information Stock Information FAQs 2 0.44 % No
Information FAQs Email Alert 2 0.44 % No
Stock Information FAQs Email 2 0.44 % No
Galectin3 About the NAVIGATE 2 0.44 % No
About the NAVIGATE Study 2 0.44 % No
malignant diseases Learn More 2 0.44 % No
and malignant diseases Learn 2 0.44 % No
fibrotic and malignant diseases 2 0.44 % No

Mobile Friendly Check


Mobile Friendly : Unknown
Score : Unknown

No data to show.

Websites Hosted on Same IP (i.e. 66.96.161.165)

South Carolina Search Engine Optimization & Web Design Company -...

- palmettosoft.com

PalmettoSoft is a SC based SEO & Digital Marketing company providing expert level SEO & Digital Marketing services for improved search rankings and increased traffic.

  421,482   $ 10,080.00

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Sun, 20 Jun 2021 19:22:39 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 7585
Connection: keep-alive
Server: Apache/2
X-Powered-By: PHP/7.3.2
Link: ; rel=shortlink
Vary: Accept-Encoding,User-Agent
Content-Encoding: gzip
Age: 3

Domain Information

Domain Registrar: GoDaddy.com, LLC
Registration Date: 2010-02-13 1 decade 4 years 3 months ago
Last Modified: 2020-01-13 4 years 4 months 21 hours ago

Domain Nameserver Information

Host IP Address Country
ns47.domaincontrol.com 97.74.103.24 United States United States
ns48.domaincontrol.com 173.201.71.24 United States United States

DNS Record Analysis

Host Type TTL Extra
galectintherapeutics.com A 1792 IP: 66.96.161.165
galectintherapeutics.com NS 3600 Target: ns47.domaincontrol.com
galectintherapeutics.com NS 3600 Target: ns48.domaincontrol.com
galectintherapeutics.com SOA 3600 MNAME: ns47.domaincontrol.com
RNAME: dns.jomax.net
Serial: 2021041204
Refresh: 28800
Retry: 7200
Expire: 604800
galectintherapeutics.com MX 3600 Target: galectintherapeutics-com.mail.protection.outlook.com
galectintherapeutics.com TXT 3600 TXT: v=spf1 include:spf.smarsh.com
include:spf.protection.outlook.com -all
galectintherapeutics.com TXT 3600 TXT: v=verifydomain MS=6038271

Alexa Traffic Rank

Alexa Search Engine Traffic

Full WHOIS Lookup

Domain Name: GALECTINTHERAPEUTICS.COM
Registry Domain ID:
1585206836_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2020-01-13T14:20:09Z
Creation Date:
2010-02-12T16:12:27Z
Registry Expiry Date:
2022-02-12T16:12:27Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS47.DOMAINCONTROL.COM
Name Server:
NS48.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2021-06-20T19:22:25Z

Similarly Ranked Websites

Nordstrom's Automotive – Used Auto Parts – Sioux Falls SD

- nordstromsauto.com

2,075,206   $ 720.00

FRONTOWIEC.COM

- frontowiec.com

Jesteśmy fascynatami militarnej historii ostatnich czasów. Kolekcjonujemy wszelkiego typu militaria i materiały historyczne.

2,075,213   $ 720.00

Génération Nintendo : Actu, Critiques, Passion

- generation-nintendo.com

Joignez-vous à une communauté active, chaleureuse et passionnée de fans de Nintendo, et découvrez nos news, tests, dossiers, astuces, fiches et bien plus encore !

2,075,221   $ 720.00

Fraser – Leader in Autism Services Other Special Needs |...

- fraser.org

Fraser serves children and adults with special needs through comprehensive education, healthcare and housing services. Fraser is Minnesota's largest and most experienced...

2,075,241   $ 720.00

Пчёлка - медовые рецепты, все о мёде и пчёлах

- meedov.ru

На сайте вы можете найти информацию о мёде, пчёлах и продуктах пчеловодства.

2,075,257   $ 720.00